Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 13

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 13
---
-1 Warrants. If holders of the Class H-1 Warrants elect the zero exercise price option, on this basis, such exercise will result in substantial dilution to stockholders. The Common Stock Warrants are not exercisable until Stockholder Approval and may not have any value. Under Nasdaq listing rules, the Common Stock Warrants are not exercisable without Stockholder Approval for the issuance of shares issuable upon exercise of such Common Stock Warrants. While we intend to use reasonable best efforts to seek Stockholder Approval for issuances of shares of common stock issuable upon exercise of the Common Stock Warrants, there is no guarantee that the Stockholder Approval will ever be obtained. The Common Stock Warrants will be exercisable commencing on the date Stockholder Approval is obtained, at an initial exercise price per share of $ per share. In the event that the price of a share of our common stock does not exceed the exercise price of the Common Stock Warrants during the period when the Common Stock Warrants are exercisable, the Common Stock Warrants may not have any value. If we are unable to obtain the Stockholder Approval, the Common Stock Warrants will not be exercisable and therefore would have no value. In addition, we may incur substantial cost, and management may devote substantial time and attention, in attempting to obtain Stockholder Approval of the issuance of shares of common stock upon exercise of the Common Stock Warrants issued in this offering. 7 Holders of the warrants offered hereby will have no rights as common stockholders with respect to the shares our common stock underlying the warrants until such holders exercise their warrants and acquire our common stock, except as otherwise provided in the warrants. Until holders of the warrants and the pre-funded warrants acquire shares of our common stock upon exercise thereof, such holders will have no rights with respect to the shares of our common stock underlying such warrants, except to the extent that holders of such warrants will have certain rights to participate in distributions or dividends paid on our common stock as set forth in the warrants. Upon exercise of the common warrants and the pre-funded warrants, the holders will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after the exercise date. This is a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we believe is required for our business plans, including our near-term business plans. The placement agent has agreed to use its reasonable best efforts to solicit offers to purchase